China Jo-Jo Drugstores Inc.
| 0.1913 | -0.0007 | -0.36% | Vol 606.00K | 1Y Perf -89.33% |
| Nov 30th, 2023 15:59 DELAYED |
| BID | 0.1902 | ASK | 0.2138 | ||
| Open | 0.2000 | Previous Close | 0.1920 | ||
| Pre-Market | - | After-Market | 0.20 | ||
| - - | 0.01 3.55% |
| Target Price | - | Analyst Rating | — 0.00 | |
| Potential % | - | Finscreener Ranking | — - | |
| Insiders Trans % 3/6/12 mo. | -/-/- | Value Ranking | ★+ 43.39 | |
| Insiders Value % 3/6/12 mo. | -/-/- | Growth Ranking | + 29.48 | |
| Insiders Shares Cnt. % 3/6/12 mo. | -/-/- | Income Ranking | — - | |
| Price Range Ratio 52W % | 0.23 | Earnings Rating | Buy | |
| Market Cap | 7.99M | Earnings Date | 5th Oct 2023 | |
| Alpha | -0.03 | Standard Deviation | 0.29 | |
| Beta | -0.02 |
Today's Price Range 0.19000.2165 | 52W Range 0.16949.65 | 5 Year PE Ratio Range -33.70-0.5000 |
Summary:
Sell
| Technical Indicators: | Neutral |
| Moving Averages: | Strong Sell |
| Performance | |||
|---|---|---|---|
| 1 Week | 0.00% | ||
| 1 Month | -7.58% | ||
| 3 Months | -37.24% | ||
| 6 Months | -73.94% | ||
| 1 Year | -89.33% | ||
| 3 Years | -81.95% | ||
| 5 Years | -90.89% | ||
| 10 Years | -76.09% |
| Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
ROE (5Y Avg) | -13.91 | |||
ROE last 12 Months | -13.19 | |||
ROA (5Y Avg) | -2.89 | |||
ROA last 12 Months | -3.09 | |||
ROC (5Y Avg) | -11.31 | |||
ROC last 12 Months | -4.51 | |||
Return on invested Capital Q | -0.26 | |||
Return on invested Capital Y | -4.04 | |||
Assets Turnover | 0.90 | |||
Receivables Turnover | 4.50 |
| Valuation | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| -0.30 | ||||
| 1.32 | ||||
| 0.35 | ||||
| 10.40 | ||||
| -5.30 | ||||
| -18.58 | ||||
| 1.61 | ||||
| 2.82 | ||||
| 61.92M | ||||
| Forward PE | - | |||
| PEG | - |
| Financial Strength | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 0.60 | ||||
| 1.00 | ||||
| 0.28 | ||||
| 2.02 | ||||
| -7.00 | ||||
| Leverage Ratio | 10.70 |
| Profitability | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 22.20 | ||||
| -1.10 | ||||
| -0.40 | ||||
| -5.00 | ||||
| -3.29 |
| Revenue | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 86.57M | ||||
| 10.14 | ||||
| -0.21 | ||||
| 11.02 |
| Dividends | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| - | ||||
| - | ||||
| - | ||||
| - | ||||
| Payout ratio | - |
| Earnings History | Estimate | Reported | Surprise % |
|---|---|---|---|
| Q03 2021 | - | -0.15 | - |
| Q02 2021 | - | -0.04 | - |
| Q01 2021 | - | -0.01 | - |
| Q04 2020 | - | -0.09 | - |
| Q03 2020 | - | 0.02 | - |
| Q02 2020 | - | -0.04 | - |
| Q01 2020 | - | -0.07 | - |
| Q04 2019 | - | 0.12 | - |
| Earnings Per End | Estimate | Revision % | Trend |
|---|---|---|---|
| 6/2011 QR | - | - | - |
| 9/2011 QR | - | - | - |
| 3/2012 FY | - | - | - |
| 3/2013 FY | - | - | - |
| Next Report Date | - |
| Estimated EPS Next Report | - |
| Estimates Count | - |
| EPS Growth Next 5 Years % | - |
| Volume Overview | |
|---|---|
| Volume | 606.00K |
| Shares Outstanding | 41.75K |
| Shares Float | 22.69M |
| Trades Count | 640 |
| Dollar Volume | 127.14K |
| Avg. Volume | 554.81K |
| Avg. Weekly Volume | 1.03M |
| Avg. Monthly Volume | 384.42K |
| Avg. Quarterly Volume | 246.36K |
China Jo-Jo Drugstores Inc. (NASDAQ: CJJD) stock closed at 0.1913 per share at the end of the most recent trading day (a -0.36% change compared to the prior day closing price) with a volume of 606.00K shares and market capitalization of 7.99M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 1074 people. China Jo-Jo Drugstores Inc. CEO is Lei Liu.
The one-year performance of China Jo-Jo Drugstores Inc. stock is -89.33%, while year-to-date (YTD) performance is -94.65%. CJJD stock has a five-year performance of -90.89%. Its 52-week range is between 0.1694 and 9.6499, which gives CJJD stock a 52-week price range ratio of 0.23%
China Jo-Jo Drugstores Inc. currently has a PE ratio of -0.30, a price-to-book (PB) ratio of 1.32, a price-to-sale (PS) ratio of 0.35, a price to cashflow ratio of 10.40, a PEG ratio of -, a ROA of -3.09%, a ROC of -4.51% and a ROE of -13.19%. The company’s profit margin is -3.29%, its EBITDA margin is -0.40%, and its revenue ttm is $86.57 Million , which makes it $10.14 revenue per share.
Of the last four earnings reports from China Jo-Jo Drugstores Inc., there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. China Jo-Jo Drugstores Inc.’s next earnings report date is -.
The consensus rating of Wall Street analysts for China Jo-Jo Drugstores Inc. is — (0), with a target price of $, which is 0.00% compared to the current price. The earnings rating for China Jo-Jo Drugstores Inc. stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
China Jo-Jo Drugstores Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
China Jo-Jo Drugstores Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 26.86, ATR14 : 0.02, CCI20 : -43.98, Chaikin Money Flow : -0.42, MACD : -0.01, Money Flow Index : 54.38, ROC : -14.64, RSI : 40.32, STOCH (14,3) : 27.17, STOCH RSI : 0.98, UO : 23.42, Williams %R : -72.83), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of China Jo-Jo Drugstores Inc. in the last 12-months were:
China Jo-Jo Drugstores Inc.
China Jo-Jo Drugstores Inc is a retailer and distributor of pharmaceutical products. The company's operating segments include Retail drugstores, Online Pharmacy, Drug wholesale and Herb farming. Retail drugstores segment sells prescription and over-the-counter medicines, TCM, dietary supplements, medical devices, and sundry items to retail customers. The online pharmacy segment sells drugs through third-party platforms such as Alibaba's Tmall, JD.com, and Amazon.com. It generates maximum revenue from the Retail drugstores segment.
CEO: Lei Liu
Telephone: +86 57188077078
Address: 386 Shangtang Road, Hangzhou 310008, , CN
Number of employees: 1 074
